Dewpoint Therapeutics
Sid completed his BS in Biology concentrating in Molecular Sciences at Suffolk University and has held a position at the Center of Virology and Vaccine Research at BIDMC. There, he has been extensively involved with the processing of specimens from human clinical trials testing candidate vaccines and therapeutics against HIV-1, COVID-19, and other emerging infectious pathogens. Sid has contributed to numerous projects focusing on antibody-mediated immunity to HIV-1. Sid has a particular interest in Cell Biology, his high interest in Cell Culture and his background in infectious pathogens have found him the perfect home at Dewpoint Therapeutics.
This person is not in any offices
Dewpoint Therapeutics
Dewpoint Therapeutics is the first company founded to apply the emerging discipline of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions has pathways that are regulated by condensates or arise from the dysfunction of condensates - including cancer, neurodegeneration, and metabolic disease.